Simson Jake Insider Trades

Insider Trading History

Track insider trading activity for Simson Jake. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Janux Therapeutics
Janux Therapeutics JANX
Director
Holding Value $231k 15,500 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 21,000 shares
$13.66
$14.91
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Director
Holding Value $487k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$25.00
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $396k 13,160 shares
Last Trade
May 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 13,160 shares
$32.68
$30.06
Septerna
Septerna SEPN
Director
Holding Value $608k 16,623 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 16,623 shares
$10.24
$36.57
Janux Therapeutics
Janux Therapeutics JANX
Director
Holding Value $174k 11,667 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 11,667 shares
$25.46
$14.91
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Director
Holding Value $594k 23,746 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 23,746 shares
$11.48
$25.00
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $667k 22,200 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 22,200 shares
$9.25
$30.06
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Director
Holding Value $594k 23,746 shares
Last Trade
Sep 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$25.00
Janux Therapeutics
Janux Therapeutics JANX
Director
Holding Value $124k 8,350 shares
Last Trade
Jun 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 8,350 shares
$39.80
$14.91
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $559k 18,600 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$296k 18,600 shares
$15.94
$30.06
DICE Therapeutics
DICE Therapeutics DICE
Director
Holding Value $0 0 shares
Last Trade
Aug 09, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.01M 21,250 shares
$47.55
$47.55
Janux Therapeutics
Janux Therapeutics JANX
Director
Holding Value $186k 12,500 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 12,500 shares
$13.22
$14.91
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $436k 14,500 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 14,500 shares
$14.47
$30.06
Janux Therapeutics
Janux Therapeutics JANX
Director
Holding Value $186k 12,500 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 12,500 shares
$10.73
$14.91
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $436k 14,500 shares
Last Trade
Jun 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78k 14,500 shares
$5.38
$30.06
DICE Therapeutics
DICE Therapeutics DICE
Director
Holding Value $1.01M 21,250 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 21,250 shares
$14.98
$47.55
Janux Therapeutics
Janux Therapeutics JANX
Director
Holding Value $447k 30,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up